Cancer BiologyFEBS JournalPeer-reviewed
The EGF/EGFR-YAP1/TEAD2 axis-mediated BRAF inhibitor vemurafenib resistance upregulates STIM1 in melanoma
Weiyu Bai, Chenghao Yan, Yichen Yang…·Jianwei Sun
This study identifies the EGF/EGFR-YAP1/TEAD2 axis as a mechanism by which vemurafenib resistance upregulates STIM1 in melanoma.
19 citations